Treatment-naive cancer patients show subclinical myocardial fibrosis, indicated by elevated native T1 and reduced global longitudinal strain compared to healthy controls.
Does treatment-naive diffuse large B cell lymphoma cause subclinical myocardial alterations detectable by CMR compared to healthy controls?
Treatment-naive DLBCL patients exhibit subclinical myocardial alterations characterized by elevated native T1 and reduced GLS, suggesting cancer-related myocardial remodeling precedes cardiotoxic therapy.
Absolute Event Rate: 0% vs 0%
Treatment-naive cancer patients exhibit subclinical myocardial alterations, characterized by elevated native T1 and reduced global longitudinal strain. Cardiac magnetic resonance emerges as a valuable tool for identifying early biomarkers of myocardial dysfunction, offering opportunities for risk stratification and proactive management in cardio-oncology.
Catapano et al. (Wed,) reported a other. Treatment-naive cancer patients show subclinical myocardial fibrosis, indicated by elevated native T1 and reduced global longitudinal strain compared to healthy controls.